Australia’s first major snapshot into chronic thromboembolic pulmonary hypertension (CTEPH) shows long-term survival rates are on par with international outcomes, but greater access to and awareness of treatment options are needed to optimise care. A review of the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) registry explored outcomes for 386 patients diagnosed with ...
First Australian snapshot of CTEPH reveals opportunities for better care
By Natasha Doyle
7 Oct 2021